Evidence map

ReviewCells2026

Precision Immunotherapeutics for Glioblastoma: Current Approaches and Emerging Strategies in 2026.

James Poe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

2 papers cite it

2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 41892350